Colorectal cancer patients with defects in mismatch repair — one of the body’s systems for repairing DNA damage — have lower recurrence rates and better survival rates than patients without such defects, according to a new study.
Colorectal cancer patients with defects in mismatch repair — one of the body’s systems for repairing DNA damage — have lower recurrence rates and better survival rates than patients without such defects, according to a new study.